Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Closed-loop auditory feedback for the improvement of gait in patients with Parkinson's disease.

Baram Y, Aharon-Peretz J, Badarny S, Susel Z, Schlesinger I.

J Neurol Sci. 2016 Apr 15;363:104-6. doi: 10.1016/j.jns.2016.02.021. Epub 2016 Feb 10.

PMID:
27000231
2.

Virtual reality feedback cues for improvement of gait in patients with Parkinson's disease.

Badarny S, Aharon-Peretz J, Susel Z, Habib G, Baram Y.

Tremor Other Hyperkinet Mov (N Y). 2014 Apr 1;4:225. doi: 10.7916/D8V69GM4. eCollection 2014.

3.
4.

Effect of ropinirole on visuo-motor test in newly diagnosed Parkinson's disease patients.

Badarny S, Stern A, Susel Z, Honigman S, Hocherman S.

Acta Neurol Scand. 2006 May;113(5):294-300.

PMID:
16629764
5.

Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.

Engber TM, Marin C, Susel Z, Chase TN.

Eur J Pharmacol. 1993 Jun 4;236(3):385-93.

PMID:
8102970
6.

Effects of chronic levodopa on D1 and D2 receptor-mediated striatal output.

Engber TM, Susel Z, Weick BG, Walters JR, Chase TN.

Neurochem Int. 1992 Mar;20 Suppl:255S-260S. No abstract available.

PMID:
1365437
7.
8.

Striatal D1 dopamine receptor morphochemistry following continuous or intermittent L-dopa replacement therapy.

Ariano MA, Engber TM, Susel Z, Chase TN.

Exp Neurol. 1991 Apr;112(1):112-8.

PMID:
1826481
9.

Prolonged infusion of quinolinic acid into rat striatum as an excitotoxic model of neurodegenerative disease.

Susel Z, Engber TM, Kuo S, Chase TN.

Neurosci Lett. 1991 Jan 2;121(1-2):234-8.

PMID:
1826944
10.

[Protective therapy in Parkinson's disease].

Susel Z, Yarnitsky D.

Harefuah. 1990 Dec 16;119(12):445-6. Review. Hebrew. No abstract available.

PMID:
2127413
11.

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.

Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ Jr, Sibley DR.

Science. 1990 Dec 7;250(4986):1429-32.

PMID:
2147780
12.
14.

[Excitatory amino acid and their involvement in pathological processes in the brain].

Susel Z.

Harefuah. 1990 Mar 15;118(6):354-8. Review. Hebrew. No abstract available.

PMID:
2189816
15.

Behavioral evaluation of the anti-excitotoxic properties of MK-801: comparison with neurochemical measurements.

Susel Z, Engber TM, Chase TN.

Neurosci Lett. 1989 Sep 25;104(1-2):125-9.

PMID:
2530473
16.

Continuous and intermittent levodopa differentially affect rotation induced by D-1 and D-2 dopamine agonists.

Engber TM, Susel Z, Juncos JL, Chase TN.

Eur J Pharmacol. 1989 Sep 22;168(3):291-8.

PMID:
2573533
17.

Continuous and intermittent levodopa differentially affect basal ganglia function.

Juncos JL, Engber TM, Raisman R, Susel Z, Thibaut F, Ploska A, Agid Y, Chase TN.

Ann Neurol. 1989 May;25(5):473-8.

PMID:
2774488
18.

[Guillain-Barré syndrome after injection of sheep cells].

Susel Z, Szwarc M.

Harefuah. 1988 Jun 1;114(11):536-8. Hebrew. No abstract available.

PMID:
3396990

Supplemental Content

Support Center